Sam-A Pharm. Co. Ltd Total Assets
Sam-A Pharm. Co. Ltd total assets. Based on the latest financial reports, Sam-A Pharm. Co. Ltd (009300) holds total assets worth ₩247.04 Billion KRW (≈ $167.42 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see how much is Sam-A Pharm. Co. Ltd worth for the company's overall valuation and market capitalisation.
Total Assets of Sam-A Pharm. Co. Ltd (2009–2025)
Total assets of Sam-A Pharm. Co. Ltd from 2009 to 2025. This chart illustrates how Sam-A Pharm. Co. Ltd's total assets have evolved over time, based on quarterly financial data. See Sam-A Pharm. Co. Ltd (009300) share price today for real-time trading data and today's change.
Sam-A Pharm. Co. Ltd - Asset Composition Analysis
Sam-A Pharm. Co. Ltd Total Assets Breakdown (December 2025)
Sam-A Pharm. Co. Ltd total assets breakdown as of December 2025. Sam-A Pharm. Co. Ltd's total assets of ₩247.04 Billion consist of 55.0% current assets and 45.0% non-current assets.
| Asset Category | Amount (KRW) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 2.7% |
| Accounts Receivable | ₩19.47 Billion | 7.9% |
| Inventory | ₩16.47 Billion | 6.7% |
| Property, Plant & Equipment | ₩0.00 | 0.0% |
| Intangible Assets | ₩4.64 Billion | 1.9% |
| Goodwill | ₩0.00 | 0.0% |
Asset Composition Trend (2009–2025)
This chart illustrates how Sam-A Pharm. Co. Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore Sam-A Pharm. Co. Ltd current assets vs equity to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Sam-A Pharm. Co. Ltd's current assets represent 55.0% of total assets in 2025, an increase from 42.8% in 2009.
- Cash Position: Cash and equivalents constituted 2.7% of total assets in 2025, down from 11.7% in 2009.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 1.0% of total assets, an increase from 0.0% in 2009.
- Asset Diversification: The largest asset category is accounts receivable at 7.9% of total assets.
Sam-A Pharm. Co. Ltd Competitors by Total Assets
Key competitors of Sam-A Pharm. Co. Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
GeneBioTech Co. Ltd
KQ:086060
|
Korea | ₩80.28 Billion |
|
Sam Chun Dang Pharm. Co. Ltd
KQ:000250
|
Korea | ₩575.39 Billion |
|
ST Pharm Co.Ltd
KQ:237690
|
Korea | ₩782.57 Billion |
|
NatureCell Co.Ltd
KQ:007390
|
Korea | ₩71.32 Billion |
|
Oscotec Inc
KQ:039200
|
Korea | ₩267.18 Billion |
|
Komipharm International Co. Ltd
KQ:041960
|
Korea | ₩133.92 Billion |
|
Mezzion Pharma Co.Ltd
KQ:140410
|
Korea | ₩125.25 Billion |
|
Aprogen Healthcare & Games Inc
KQ:109960
|
Korea | ₩324.89 Billion |
Sam-A Pharm. Co. Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 9.78 | 5.51 | 10.80 |
| Quick Ratio | 8.60 | 4.82 | 9.41 |
| Cash Ratio | 0.00 | 0.47 | 0.00 |
| Working Capital | ₩121.98 Billion | ₩92.58 Billion | ₩83.19 Billion |
Sam-A Pharm. Co. Ltd - Advanced Valuation Insights
This section examines the relationship between Sam-A Pharm. Co. Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.43 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -0.7% |
| Total Assets | ₩247.04 Billion |
| Market Capitalization | $56.13 Million USD |
Valuation Analysis
Below Book Valuation: The market values Sam-A Pharm. Co. Ltd's assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Sam-A Pharm. Co. Ltd's assets decreased by 0.7% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Sam-A Pharm. Co. Ltd (2009–2025)
The table below shows the annual total assets of Sam-A Pharm. Co. Ltd from 2009 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | ₩247.04 Billion ≈ $167.42 Million |
-0.68% |
| 2024-12-31 | ₩248.73 Billion ≈ $168.56 Million |
+7.53% |
| 2023-12-31 | ₩231.31 Billion ≈ $156.75 Million |
+13.83% |
| 2022-12-31 | ₩203.20 Billion ≈ $137.70 Million |
+7.41% |
| 2021-12-31 | ₩189.17 Billion ≈ $128.20 Million |
+3.88% |
| 2020-12-31 | ₩182.11 Billion ≈ $123.41 Million |
-4.55% |
| 2019-12-31 | ₩190.78 Billion ≈ $129.29 Million |
+9.84% |
| 2018-12-31 | ₩173.69 Billion ≈ $117.70 Million |
+3.40% |
| 2017-12-31 | ₩167.97 Billion ≈ $113.83 Million |
+3.51% |
| 2016-12-31 | ₩162.27 Billion ≈ $109.97 Million |
+6.13% |
| 2015-12-31 | ₩152.91 Billion ≈ $103.62 Million |
+4.83% |
| 2014-12-31 | ₩145.86 Billion ≈ $98.85 Million |
+0.74% |
| 2012-12-31 | ₩144.79 Billion ≈ $98.12 Million |
+5.02% |
| 2011-12-31 | ₩137.86 Billion ≈ $93.43 Million |
+7.08% |
| 2010-12-31 | ₩128.75 Billion ≈ $87.25 Million |
+15.89% |
| 2009-12-31 | ₩111.10 Billion ≈ $75.29 Million |
-- |
About Sam-A Pharm. Co. Ltd
Sam-A Pharm. Co., Ltd operates as a pharmaceutical company in South Korea. The company offers a range of pharmaceutical products in the areas of respiratory, anti-biotics, anti-virals, anti-histamines, anti-fungals, dermatology, pain/inflammation, gastrointestinal, cardiovascular, metabolism, urological, and steroids, as well as psychotropic agents; and OTC products in the areas of respiratory, a… Read more